EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer

Ru-Yi Chen, Li-Jian Ding, Yan-Jun Liu, Jin-Jin Shi, Jing Yu, Chang-Yun Li iD, Jian-Fei Lu iD, Guan-Jun Yang iD, Jiong Chen iD

Marine Drugs · 2024

DOI: 10.3390/md22100459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Ru-Yi Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo Universit…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Staurosporine, Apoptosis, Cell Movement. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Starting Research Fund of Ningbo University, Ningbo youth science and technology innovation leading project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with high mortality and drug resistance and no targeted drug available at present. Compound 4, a staurosporine alkaloid derived from Streptomyces sp. NBU3142 in a marine sponge, exhibits potent anti-TNBC activity. This research investigated its impact on MDA-MB-231 cells and their drug-resistant variants. The findings highlighted that compound 4 inhibits breast cancer cell migration, induces apoptosis, arrests the cell cycle, and promotes cellular senescence in both regular and paclitaxel-resistant MDA-MB-231 cells. Additionally, this study identified mitogen-activated protein kinase kinase kinase 11 (MAP3K11) as a target of compound 4, implicating its role in breast tumorigenesis by affecting cell proliferation, migration, and cell cycle progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsStaurosporineApoptosisCell MovementAntineoplastic AgentsCell ProliferationHumansCell Line, TumorAnimalsFemalePoriferaStreptomycesDrug Resistance, NeoplasmMAP Kinase Kinase KinasesCellular Senescence

Stichwörter der Autor:innen

MAP3K11apoptosiscancer stem cellscell migrationstaurosporine analoguetriple-negative breast cancer

Substanzen

StaurosporineAntineoplastic AgentsMAP Kinase Kinase Kinases

Autor:innen und Institutionen

  • State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, School of Marine Sciences, Ningbo University, Ningbo 315211, China.
  • School of Pharmacy, Health Science Center, Ningbo University, Ningbo 315211, China.

ORCID-Profile: Chang-Yun Li, Jian-Fei Lu, Guan-Jun Yang, Jiong Chen

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Starting Research Fund of Ningbo University
  • Ningbo youth science and technology innovation leading project

Zitieren

APA

Chen, R. Y., Ding, L. J., Liu, Y. J., Shi, J. J., Yu, J., Li, C. Y., Lu, J. F., Yang, G. J., & Chen, J. (2024). Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer. Marine Drugs. https://doi.org/10.3390/md22100459

Vancouver

Chen RY, Ding LJ, Liu YJ, Shi JJ, Yu J, Li CY, et al. Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer. Marine Drugs. 2024. doi:10.3390/md22100459

BibTeX
@article{Chen2024,
  author = {Chen, Ru-Yi and Ding, Li-Jian and Liu, Yan-Jun and Shi, Jin-Jin and Yu, Jing and Li, Chang-Yun and Lu, Jian-Fei and Yang, Guan-Jun and Chen, Jiong},
  title = {Marine Staurosporine Analogues: Activity and Target Identification in Triple-Negative Breast Cancer},
  journal = {Marine Drugs},
  year = {2024},
  doi = {10.3390/md22100459}
}
Kostenlos starten →